Core Viewpoint - Huajian Medical has announced the establishment of the ETHK Building in Nanjing, marking a significant milestone in its transformation into a global innovator in digital industry and blockchain financial infrastructure [1] Group 1: ETHK Building and Its Significance - The ETHK Building, with a total area of approximately 70,000 square meters, serves as the physical core of Huajian Medical's "ETHK Blockchain Financial Ecosystem Strategy" [2] - The building will host over 5,000 technical experts and partners, providing top-tier laboratories, data centers, and testing environments [2] - The completion of the ETHK Building signifies Huajian Medical's transition from conceptual leadership to large-scale physical implementation [2] Group 2: Strategic Advantages and Market Context - Huajian Medical's proactive approach to RWA infrastructure is supported by technological trends, policy benefits, and market demand [4] - The global total value locked (TVL) in RWA is projected to reach $12.5 billion by June 2025, reflecting a 124% year-on-year growth [4] - The company has established a comprehensive capability chain through joint ventures, covering technology, asset issuance, and compliance operations [4] Group 3: Long-term Strategy and Globalization - Huajian Medical's RWA strategy is a long-term investment aimed at building a robust competitive moat through technology, licensing, assets, and partnerships [6] - The company holds 5,190 ETH as treasury reserves and plans to increase its holdings, demonstrating confidence in the blockchain financial ecosystem [7] - The vision includes enabling Chinese quality assets to "go global" through RWA technology, facilitating global pricing and financing [7] Group 4: Broader Implications for the Industry - The establishment of the ETHK Building is a typical example of Chinese enterprises seizing opportunities in digital financial infrastructure [8] - As technology matures and regulations clarify, RWA is expected to become a crucial bridge connecting the real economy with the crypto world [8]

格隆汇9月19日丨华检医疗(01931.HK)宣布，为更准确反映集团全新战略定位及未来发展方向，公司决 定采用全新企业标志，自2025年9月19日起生效。公司的旧标志及新标志载列如下，以供识别： 公告显示，此次更新公司标志，并非止于视觉形象之更迭，而是集团战略愿景、生态格局与品牌哲学演 进的外在彰显，具有深远的战略意义与品牌价值。 新标志将印制于公司相关公司文件(包括但不限于中期及年度报告、公告、通函、通告、股票及新闻稿) 及将于公司官方网站展示。 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 對 因 本 公 告全部或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何 責 任。 IVD Medical Holding Limited 華檢醫療控股有限公司 （於開曼群島註冊成立之有限公 司） （股份代號：1931） 自願性公告 全球首個RWA大 廈－ETHK大廈正式落成 ETHK鏈 上 金 融 生 態 戰 略 邁 入 實 體 化、規 模 化 技 術 落 地 新 紀 元 本 公 告 乃 由 華 檢 醫 療 控 股 有 限 公 司（「本公司」或「華檢醫療」，連 同 其 附 屬 公 司 統 稱「本集團」）自 願 作 出，旨 在 向 股 東 及 潛 在 投 資 者 提 供 本 集 團 業 務 發 展 的 最 新 資 料。 本 公 司 董 事 會（「董事會」）欣 然 宣 佈，由 本 集 團 傾 力 打 造 的 全 球 首 個 專 注 於 現 實 世 界 資 產（RWA）數 字 化 技 術 研 發 與 生 態 賦 能 的 核 心 基 地 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 對 因 本 公 告全部或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何 責 任。 更 換 企 業 標 誌（更 新LOGO） 華 檢 醫 療 控 股 有 限 公 司（「本公司」）董 事 會（「董事會」）謹 此 宣 佈，本 公 司 已 於 二 零 二 五 年 九 月 十 九 日 起 採 用 新 標 誌。本 公 司 舊 標 誌 與 新 標 誌 載 列 如 下，以 供 識 別： 一、新 標 誌（LOGO）介 紹 本 公 司 董 事 會（「董事會」）欣 然 宣 佈，為 更 準 確 反 映 本 集 團 全 新 戰 略 定 位 及 未 來 發 展 方 向，本 公 司 決 定 採 用 全 新 企 業 標 誌（「新標誌」），自 二 零 二 五 年 九 月 十 九 日 起 生 效。本 公 司 之 舊 標 誌 及 新 標 誌 載 列 如 下，以 供 識 別： 舊標誌 新標誌 IVD Medical Holding Limited 華檢醫療控股有限公司 ...

Group 1 - The core viewpoint of the news is the strategic collaboration between Huajian Medical and Renhe Pharmaceutical to establish the world's first OTC-focused Real World Asset (RWA) exchange in the United States, highlighting the growing interest and cautious optimism in the RWA sector [1][6][9] - The RWA market is gaining traction, with a projected market size of $16 trillion by 2030, prompting numerous companies in both A-shares and Hong Kong stocks to enter the space [2][5] - Huajian Medical's "ETHK global RWA exchange" aims to create a comprehensive ecosystem for asset tokenization, connecting various industries with financial institutions [5][6][9] Group 2 - The RWA sector is characterized by a disparity in development between the U.S. and China, with the U.S. having a more established infrastructure for asset tokenization [5] - Companies like Langxin Group and GCL-Poly Energy have taken the lead in RWA practices in China, successfully completing projects that tokenize renewable energy assets [2] - The collaboration between Huajian Medical and Renhe Pharmaceutical is seen as a significant step for Chinese listed companies to explore the RWA market, especially with the evolving global regulatory framework [9] Group 3 - Successful RWA initiatives require high-quality, liquid assets, with Renhe Pharmaceutical's strong brand portfolio providing significant tokenization potential [8] - The RWA industry involves various services such as asset verification, compliance auditing, and liquidity provision, benefiting related financial service providers [8] - Huajian Medical's strategic acquisitions and compliance capabilities position it well to facilitate the tokenization and cross-border trading of real-world assets [8][9]

Group 1 - The core viewpoint of the news is the strategic collaboration between Huajian Medical and Renhe Pharmaceutical to establish the world's first OTC-focused Real World Asset (RWA) exchange in the United States, indicating a significant move in the RWA market [1][5] - The RWA market is gaining traction, with a projected total market value of $16 trillion by 2030, prompting numerous companies in both A-shares and Hong Kong stocks to enter the space [2] - Huajian Medical's "ETHK Global RWA Exchange" aims to create a comprehensive trading ecosystem for real-world assets, providing services such as asset selection, compliance issuance, and liquidity management [4][5] Group 2 - The RWA market is characterized by a growing number of companies, including Langxin Group and Xiexin Nengke, which are pioneering RWA practices in China through partnerships with Ant Group [2] - The infrastructure for RWA in China is still developing, with many companies facing challenges in finding comprehensive service providers for asset tokenization [4] - Huajian Medical's strategic acquisitions and compliance qualifications in overseas markets enhance its capability to provide end-to-end solutions for asset tokenization [8] Group 3 - Companies with high-quality, growth-potential assets are more likely to succeed in the RWA space, as exemplified by Renhe Pharmaceutical's strong brand portfolio and intellectual property assets [7] - The RWA industry chain involves various services, including asset verification, technology development, and liquidity provision, benefiting related financial institutions and service providers [7] - The recent market movements reflect a complex investor sentiment towards the RWA sector, with Renhe Pharmaceutical's stock rising by 5.49% and Huajian Medical's stock experiencing significant volatility [1]

Group 1 - The core announcement from Huajian Medical involves the establishment of two joint ventures, ETHK Inc. and ETHK HOLDINGS LIMITED, aimed at enhancing the global blockchain financial ecosystem through the "ETHK" brand [1][4] - The company is undergoing a significant rebranding, changing its English name from "IVD Medical Holding Limited" to "ETHK Labs Inc." and its Chinese name to "华检数字产业集团有限公司" [1][4] - The strategic shift towards blockchain finance is a result of long-term planning, with ETHK Inc. focusing on developing a decentralized financial platform and ETHK HOLDINGS LIMITED serving as a central hub for digital industry investment and mergers [6][9] Group 2 - The "ETHK" brand symbolizes a new digital financial ecosystem based on blockchain, emphasizing openness, transparency, and community governance [9] - Huajian Medical's strategy includes the tokenization of equity assets, particularly targeting high-quality Chinese assets for efficient global circulation and value discovery [9][12] - The company has acquired a 20.31% stake in Guofu Quantum, becoming its largest shareholder, which strengthens its compliance support in the blockchain finance sector [12] Group 3 - The concept of "on-chain stocks" represents a revolutionary trend in global finance, with Huajian Medical's approach being a unique "Chinese solution" that integrates technology, assets, funding, and compliance into a closed-loop blockchain financial ecosystem [10][12] - This approach contrasts with existing U.S. tokenization products, which often lack direct backing from the underlying companies, highlighting the potential for arbitrage opportunities [12] - Huajian Medical's ETHK ecosystem aims to meet the rigorous demands of high-frequency, high-value financial transactions, facilitating the globalization of Chinese assets through compliant and standardized methods [12][14] Group 4 - The strategic upgrade aligns with China's digital economy initiatives, which encourage technological innovation and digital transformation [13][14] - Huajian Medical's efforts are positioned to provide the necessary technological pathways and infrastructure support for the globalization of Chinese assets [14] - The ETHK ecosystem is expected to bridge traditional finance and blockchain finance, promoting the efficient circulation and value discovery of high-quality Chinese assets on a global scale [15]

Core Viewpoint - Huajian Medical is undergoing a significant transformation by embracing blockchain finance, marking a strategic shift towards the tokenization of equity assets, particularly focusing on Chinese assets for global compliance and value discovery [4][5][12]. Group 1: Company Transformation - Huajian Medical announced the establishment of two joint ventures, ETHK Inc. and ETHK HOLDINGS LIMITED, to deepen its global blockchain financial ecosystem strategy [1][5]. - The company plans to change its English name from "IVD Medical Holding Limited" to "ETHK Labs Inc." and its Chinese name to "华检数字产业集团有限公司" [1][3]. - The strategic shift is a result of long-term planning, aiming to create a decentralized financial platform that is safe, efficient, compliant, and open [5][9]. Group 2: Blockchain Financial Ecosystem - The ETHK brand symbolizes a new digital financial ecosystem based on blockchain, emphasizing community governance and shared infrastructure [9]. - The ecosystem will focus on the tokenization of equity assets, including "on-chain stocks," to facilitate the global flow and value discovery of high-quality assets, especially from China [9][12]. - Huajian Medical's acquisition of a 20.31% stake in Guofu Quantum will strengthen its position in the blockchain finance sector, providing robust compliance support [9]. Group 3: On-Chain Stocks - "On-chain stocks" represent a cutting-edge trend in global finance, allowing for the tokenization of traditional financial assets [10]. - The collaboration between Galaxy Digital and Superstate marks a significant milestone in the direct tokenization of stocks on major blockchains, enhancing transparency and programmability [10][11]. - Huajian Medical's approach to on-chain stocks differs from existing U.S. models by integrating a complete ecosystem that includes technology, assets, funding, and compliance [11][12]. Group 4: Strategic Significance for Chinese Assets - Huajian Medical's blockchain strategy aligns with China's digital economy initiatives, providing a pathway for the globalization of Chinese assets through compliant and standardized tokenization [12][13]. - The company's efforts support the Chinese government's policies aimed at promoting technological innovation and digital transformation [12][13]. - The ETHK ecosystem is positioned to facilitate the efficient circulation and value discovery of Chinese assets on a global scale [14].

Major Events - Health 160 (02656) received a subscription rate of 751.77 times for its public offering in Hong Kong, with listing scheduled for September 17 [1] - Huajian Medical (01931) and Renhe International have reached a significant strategic cooperation to establish the world's first vertical RWA exchange focused on the OTC sector [1] - Giant Legend (06683) strategically invested in the operation company of the Bird's Nest to enhance IP and landmark synergy [1] - Yuexiu Property (00123) successfully acquired the Kangqiao land in Hangzhou's Gongshu District for 1.33 billion [1] - China Jinmao (00817) plans to increase capital by 350 million to Beijing Chaoyang and 2.15 billion to Beijing Manmao [1] - Sichuan Energy Investment Development (01713) signed a construction contract with Degge Gesaer Power for development [1] - Qianxun Technology (01640) signed a memorandum of understanding for the proposed acquisition of 100% equity in Punk Code Technology [1] - GCL-Poly Energy (03800) clarified that the profit statement for August-September is not an annual forecast, but based on the trend of polysilicon prices and disclosed data [1] Operating Performance - China Shenhua (01088) reported a coal production of 28.6 million tons in August, a year-on-year decrease of 0.3% [1] - Nanshun (Hong Kong) (00411) announced annual results with a net profit of 303 million HKD, representing a year-on-year increase of 51% [1]

Group 1 - The company, Huajian Medical (01931.HK), announced a share buyback on September 16, spending 13.056 million to repurchase 1.211 million shares [1]